Related Experiment Video

Updated: Mar 20, 2026

A Mouse Model of Pulmonary Fibrosis Induced by Nasal Bleomycin Nebulization
02:46

A Mouse Model of Pulmonary Fibrosis Induced by Nasal Bleomycin Nebulization

Published on: January 20, 2023

5.1K

Nebulized liposomal amphotericin prophylaxis in lung transplantation: shall we take it or leave it?

Fabrizio Vianello1, Marta Fiscon1, Monica Loy2

  • 1Department of Medicine, University of Padova, Padova, Italy.

Transplant International : Official Journal of the European Society for Organ Transplantation
|May 31, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

2.2K
Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment
09:02

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment

Published on: June 28, 2018

14.5K

Related Experiment Videos

Last Updated: Mar 20, 2026

A Mouse Model of Pulmonary Fibrosis Induced by Nasal Bleomycin Nebulization
02:46

A Mouse Model of Pulmonary Fibrosis Induced by Nasal Bleomycin Nebulization

Published on: January 20, 2023

5.1K
Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

2.2K
Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment
09:02

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment

Published on: June 28, 2018

14.5K

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

1
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
1
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

2.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.2K

Articles linked to this work by shared authors, journal, and citation graph.

Immune signatures associated with human adrenocortical hypertension.

European journal of endocrinology·2026

DLBCL-microenvironment interactions: cytokine profiling and ECM-mediated ibrutinib resistance in a 3D bone-based model.

Medical oncology (Northwood, London, England)·2026

Differential effects of legacy and new-generation perfluoro-alkyl substances on in vitro differentiation and immunoglobulins production by B cells.

Environment international·2026

From variant detection to interpretation in idiopathic erythrocytosis: A structured approach applied to a clinical cohort.

British journal of haematology·2026

B-cell and plasma cell proliferations associated with T follicular helper cell lymphomas: clinical-pathological and genetic features.

Virchows Archiv : an international journal of pathology·2026

Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real-World International Experience.

American journal of hematology·2026

Alcohol-related liver disease and access to liver transplantation: where we stand and where we should go.

Transplant international : official journal of the European Society for Organ Transplantation·2026

Kidney-alone transplantation in prior SLK candidates: a national registry analysis.

Transplant international : official journal of the European Society for Organ Transplantation·2026

Abdominal normothermic regional perfusion is associated with improved graft survival in liver transplantation from circulatory death donors.

Transplant international : official journal of the European Society for Organ Transplantation·2026

Hypoimmune platforms: from rejection to immune evasion and regulatory implications.

Transplant international : official journal of the European Society for Organ Transplantation·2026

Improving outcomes in donation after circulatory death vs. donation after brain death liver transplantation for acute-on-chronic liver failure.

Transplant international : official journal of the European Society for Organ Transplantation·2026

Potential for donation after circulatory death in Germany: a multicenter retrospective study at seven university hospitals.

Transplant international : official journal of the European Society for Organ Transplantation·2026

Beyond the pill count: unmasking the pharmacokinetic drivers of recurrent tuberculosis.

BMJ case reports·2026

Fenbufen suppresses VSMC phenotypic switching and neointimal hyperplasia by targeting HAS2.

Biochemical pharmacology·2026

Novel β-lactam-Octenidine nanoGUMBOS: A promising platform to address Bacteria linked to chronic wound infections.

Bioorganic chemistry·2026

[Retracted] PYGB siRNA inhibits the cell proliferation of human osteosarcoma cell lines.

Molecular medicine reports·2026

Sugammadex for preventIoN oF pOst-operative pulmoNary complIcAtions (SINFONIA): protocol for an embedded mixed-methods process evaluation.

BJA open·2026

Enhancing blood transfusion safety through RFID-based verification and human factors engineering.

Frontiers in medical technology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us